A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)

Jatin Patel(Age UK), Mark Layton(Age UK), Gerard J. Criner(Temple University Hospital), Xavier Bocca Ruiz, Mark Tidswell(Tufts University), Lorrie Schifano(Research Triangle Park Foundation), Eduardo Sprinz(Hospital de Clínicas de Porto Alegre), Nicolas Terzi(Inserm), Julia E. Smith(Age UK), Gaëtan Plantefève(Centre Hospitalier Victor Dupouy), Emily Jarvis(Age UK), Timothy Hatlen(UCLA Medical Center), Ciara O’Shea(GlaxoSmithKline (Ireland)), Charlotte Summers(University of Cambridge), Michinori Shirano(Osaka City General Hospital), Yuliya Trefilova(Perm Regional Oncology Center), Dave Inman(Age UK), Pedro Martínez-Ayala(Hospital Civil de Guadalajara), Duncan Wyncoll(Guy's and St Thomas' NHS Foundation Trust), Tatiana Kropotina(Budgetary Healthcare Institution of Omsk Region Regional Clinical Hospital), Zainab Shahid(Memorial Sloan Kettering Cancer Center), John D. Isaacs(Newcastle upon Tyne Hospitals NHS Foundation Trust), Jessica Neisen(Age UK), Anthony Cahn(GlaxoSmithKline (United Kingdom)), Damon Bass(Research Triangle Park Foundation), Kate Hanrott(Age UK), Jean-Claude Lachérade(Roche (France)), Anubha Gupta(Indraprastha Institute of Information Technology Delhi), Sumanta Mukherjee(GlaxoSmithKline (United States)), Rosana Muñoz-Bermúdez, Albertus Beishuizen(Medisch Spectrum Twente), R. Williamson(Age UK), Lee Schwab(Holy Cross Hospital), Divya Lakshminarayanan(GlaxoSmithKline (United States)), Pablo Alexis Doreski, Bruno François(Inserm), Charlene McEvoy(Birmingham VA Medical Center), Sofia Fernandes(Age UK), Ferhat Meziani(University of Copenhagen), Hugo Colombo(Hospital Privado), Mehran Monchi(Melun Hospital), Katherine Davy(Age UK), Javier de Miguel‐Díez(Universidad Complutense de Madrid), Hatem Boughanmi(Centre Hospitalier de Valenciennes), N. E. Kostina(Voronezh Regional Clinical Oncology Center)
European Respiratory Journal
October 13, 2022
Cited by 42


Related Papers